Biomerica Cash Flow - Annual (NASDAQ:BMRA)

Add to My Stocks
$3.39 $0.02 (0.59%) BMRA stock closing price Sep 18, 2018 (Closing)

For analyzing any company like Biomerica from an investment perspective, its important to check the cash flow statement. In simple terms, the cash flow statement measures the cash that has come into the company, and the cash that has gone out during a given period, while the other statements, the income statement and balance sheet, give details about Biomerica profits and Biomerica debt. Biomerica had cash and cash equivalents of $1.88M at beginning of the year and $1.22M at year end for 2017. Biomerica cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. BMRA decrease in investments stood at a value of $-0.09M for the latest year 2017.

View details of Biomerica cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jun - May201720162015201420132012201120102009
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities-0.08M--0.01M-0.52M--0.6M---0.69M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net---0.31M-0.32M---0.02M-0.1M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.09M-0.09M-0.01M-0.13M-0.25M-0.16M-0.14M-0.21M-0.08M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments-------0.16M--0.1M
Other Cash Inflow (Outflow) from Investment Activities---0.01M-0.14M---0.12M-0.05M-0.03M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares-1.1M-------
Issuance (Repayment) of Debt Securities------0.03M-0.04M-0.04M-0.14M
Increase (Decrease) in Bank & Other Borrowings-----0.04M----
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities---------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.88M1.08M1.5M2.46M1.07M-1.05M1.59M2.02M
Cash & Equivalents at Year End1.22M1.88M1.08M1.5M2.46M1.07M-1.05M1.59M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Biomerica stock price history provides insight into historical stock price fluctuations, and Biomerica stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Biomerica is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Biomerica stock price movement.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-0.72M for BMRA.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $-0.09M for BMRA stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for Biomerica.

Key Financial Ratios For Biomerica Cash Flow